Remove FDA Remove White Paper Remove World Health
article thumbnail

SQA Regulatory Surveillance Summary for May and June 2024

SQA

Participants were from regulatory medicine agencies in low-, middle-, and high-income countries; experts on and developers of screening technologies and other key stakeholders, including the World Health Organization (WHO), Interpol, UNICEF, and the United States Pharmacopeia (USP). This pilot project is a key part of that approach.

FDA 52